Evidence map›Paper›PMID 30271841›Full record

ArticleRegenerative therapy2017

Cryopreserved cultured epithelial allografts for pediatric deep partial dermal burns: Early wound closure and suppression of scarring.

Hiroko Yanaga, Yukihiro Udoh, Misa Yamamoto, Satoko Yoshii, Seiichiro Mori, Toshihiko Yamauchi, Kensuke Kiyokawa, Mika Koga, Katsu Yanaga

Open access · goldAbstract read
In one paragraph

Article in Regenerative therapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Hiroko YanagaYanaga Clinic and Tissue Culture Laboratory, 1-2-12 Tenjin, Chuo-ku, Fukuoka 810-0001, Japan.
Yukihiro UdohKurume University, Department of Plastic and Reconstructive Surgery and Maxillofacial Surgery, 67 Asahi-machi, Kurume, Fukuoka 830-0011, Japan.
Misa YamamotoYamaguchi University School of Medicine, Faculty of Health Sciences, 1-1-1 Minami-Ogushi, Ube, Yamaguchi 755-8505, Japan.
Satoko YoshiiKurume University, Department of Plastic and Reconstructive Surgery and Maxillofacial Surgery, 67 Asahi-machi, Kurume, Fukuoka 830-0011, Japan.
Seiichiro MoriKurume University, Department of Plastic and Reconstructive Surgery and Maxillofacial Surgery, 67 Asahi-machi, Kurume, Fukuoka 830-0011, Japan.
Toshihiko YamauchiKurume University, Department of Plastic and Reconstructive Surgery and Maxillofacial Surgery, 67 Asahi-machi, Kurume, Fukuoka 830-0011, Japan.
Kensuke KiyokawaKurume University, Department of Plastic and Reconstructive Surgery and Maxillofacial Surgery, 67 Asahi-machi, Kurume, Fukuoka 830-0011, Japan.
Mika KogaYanaga Clinic and Tissue Culture Laboratory, 1-2-12 Tenjin, Chuo-ku, Fukuoka 810-0001, Japan.
Katsu YanagaYanaga Clinic and Tissue Culture Laboratory, 1-2-12 Tenjin, Chuo-ku, Fukuoka 810-0001, Japan.
Kurume University · JPYamaguchi University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn deep partial thickness dermal burns (DDB) where greater than 50% of the dermis is lost, severe pain, scarring and contractures occur. Therefore, skin grafting may be required. In children, scar contracture occurs because scarred skin does not stretch with growth creating the need for additional scar-releasing or skin-grafting surgeries. In order to resolve this problem, we used cryopreserved cultured epithelial allograft (cryopreserved allo-CEG), which can be grafted shortly after sustaining a wound. We reevaluated the promotion of early wound closure of burns and suppression of scarring by this treatment.

methodsCryopreserved allo-CEGs were used to treat 50 cases of pediatric DDB from 1992 to 2000. These cases were reviewed with regard to the time until epithelialization, take percentage, and pain level. Also, in order to examine why cryopreserved allo-CEG promotes healing of burns and suppresses scarring, growth factors and cytokines in the cryopreserved allo-CEG were measured. Cryopreserved allo-CEG sheets were solubilized and concentrations of TGF-α, TGF-β1, IL-1α, IL-1β, PDGF-AA, VEGF, KGF, IL-6, b-FGF, as well as metalloprotease-1 (MMP-1) and HGF, which are noted to have scarring suppression effects, were measured before grafting.

resultsGrafting of cryopreserved allo-CEGs in 50 cases of childhood DDB resulted in early epithelialization (9.32 ± 3.63 days on the average) and an almost 100% take rate. Also, pain relief (pain reduction or elimination, reduced need for anesthetics) was seen in all cases. Although 15-23 years have now elapsed, adverse events have not been observed. Cryopreserved allo-CEG contains IL-1α, IL-1β, PDGF-AA, TGF-α, TGF-β1, VEGF, and IL-6 have wound healing effects. The concentration of IL-1α was higher than the concentrations of other components, and this was followed by TGF-α, TGF-β1, b-FGF and VEGF. Although the concentration of MMP-1, which has a scarring suppression effect, was high, HGF was not detected.

conclusionCryopreserved allo-CEG contains growth factors that promote wound healing and factors that suppress scarring. Three effects, namely (1) early wound closure, (2) scarring suppression, and (3) pain relief were seen with grafts of cryopreserved allo-CEG in cases of childhood DDB. These observations show that cryopreserved allo-CEG is clinically useful and effective for the treatment of childhood DDB.

Indexed as

Clinical applicationCryopreserved allograftEpithelial graftHuman keratinocyte

Identifiers

PMID30271841
PMCPMC6134912
OpenAlexW2604578291

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.